NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $17,960,000 | +4.7% | 1,000,000 | 0.0% | 0.58% | +37.2% |
Q2 2021 | $17,160,000 | -14.2% | 1,000,000 | 0.0% | 0.42% | -3.6% |
Q1 2021 | $20,000,000 | +198.3% | 1,000,000 | +222.0% | 0.44% | +123.9% |
Q4 2019 | $6,704,000 | -94.7% | 310,579 | -74.0% | 0.20% | -97.2% |
Q1 2018 | $126,694,000 | +15.7% | 1,192,300 | -35.0% | 7.00% | +26.8% |
Q4 2017 | $109,526,000 | +291.4% | 1,834,000 | +57.3% | 5.52% | +333.7% |
Q3 2017 | $27,986,000 | +22.8% | 1,166,100 | 0.0% | 1.27% | +4.3% |
Q2 2017 | $22,797,000 | +45.9% | 1,166,100 | +75.2% | 1.22% | +19.1% |
Q1 2017 | $15,622,000 | +58.9% | 665,600 | +16.3% | 1.02% | +18.0% |
Q3 2016 | $9,829,000 | +36.4% | 572,100 | -12.7% | 0.87% | -5.1% |
Q1 2015 | $7,205,000 | -29.0% | 655,000 | 0.0% | 0.92% | -7.9% |
Q4 2014 | $10,153,000 | – | 655,000 | – | 1.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Monaco Asset Management SAM | 4,809,601 | $2,864,598 | 0.85% |
Lynx1 Capital Management LP | 1,766,815 | $1,052,315 | 0.70% |
CM Management, LLC | 800,000 | $476,480 | 0.51% |
Deep Track Capital, LP | 18,400,000 | $10,959,040 | 0.42% |
TANG CAPITAL MANAGEMENT LLC | 3,939,600 | $2,346,426 | 0.33% |
Acuitas Investments, LLC | 721,460 | $429,702 | 0.25% |
RA Capital Management | 18,700,000 | $11,137,720 | 0.22% |
GSA CAPITAL PARTNERS LLP | 1,841,078 | $1,097 | 0.09% |
UBS OCONNOR LLC | 1,376,249 | $820,244 | 0.02% |
Marquette Asset Management, LLC | 148,378 | $88,374 | 0.02% |